Glycinebetaine
CAS 107-43-7
Glycinebetaine (CAS 107-43-7) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Hypermethioninaemia | 12 | 105.805 | 10051245 |
| Overdose | 41 | 88.995 | 10033295 |
| Intracranial pressure increased | 13 | 53.557 | 10022773 |
| Brain oedema | 16 | 52.231 | 10048962 |
| Treatment noncompliance | 18 | 45.353 | 10049414 |
| Product odour abnormal | 7 | 33.818 | 10069226 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| BETAINE | 1512 | SU | MTHSPL |
| Betaine | 1512 | SU | MTHSPL |
| betaine | 1512 | IN | RXNORM |
Side Effects
SIDER side-effect terms mapped to the drug or same-CAS compound identity.
| Side Effect | Drug Name | MedDRA Type | Concept ID |
|---|---|---|---|
| Abdominal discomfort | betaine | PT | C0232487 |
| Abdominal discomfort | betaine | PT | C0232487 |
| Agitation | betaine | LLT | C0085631 |
| Agitation | betaine | PT | C0085631 |
| Alopecia | betaine | LLT | C0002170 |
| Alopecia | betaine | PT | C0002170 |
| Anorexia | betaine | LLT | C0003123 |
| Aspiration | betaine | LLT | C0700198 |
| Aspiration | betaine | PT | C0700198 |
| Bad taste | betaine | LLT | C0541799 |
| Brain oedema | betaine | PT | C1527311 |
| Brain oedema | betaine | LLT | C1527311 |
| Brain oedema | betaine | PT | C1527311 |
| Decreased appetite | betaine | PT | C0232462 |
| Diarrhoea | betaine | LLT | C0011991 |
| Diarrhoea | betaine | PT | C0011991 |
| Distress gastrointestinal | betaine | LLT | C0548823 |
| Dysgeusia | betaine | PT | C0013378 |
| Edema cerebral | betaine | LLT | C0006114 |
| Gastrointestinal disorder | betaine | LLT | C0017178 |
| Gastrointestinal disorder | betaine | PT | C0017178 |
| Glossitis | betaine | LLT | C0017675 |
| Glossitis | betaine | PT | C0017675 |
| Headache | betaine | LLT | C0018681 |
| Headache | betaine | PT | C0018681 |
| Homocystinuria | betaine | LLT | C0019880 |
| Homocystinuria | betaine | PT | C0019880 |
| Hypermethioninaemia | betaine | LLT | C0268621 |
| Hypermethioninaemia | betaine | PT | C0268621 |
| Irritability | betaine | LLT | C0022107 |
| Irritability | betaine | PT | C0022107 |
| Malnutrition | betaine | LLT | C0162429 |
| Malnutrition | betaine | PT | C0162429 |
| Mental disorder | betaine | LLT | C0004936 |
| Mental disorder | betaine | PT | C0004936 |
| Nausea | betaine | LLT | C0027497 |
| Nausea | betaine | PT | C0027497 |
| Nervous system disorder | betaine | LLT | C0027765 |
| Nervous system disorder | betaine | PT | C0027765 |
| Personality disorder | betaine | LLT | C0031212 |
| Personality disorder | betaine | PT | C0031212 |
| Skin disorder | betaine | PT | C0037274 |
| Skin odour abnormal | betaine | LLT | C0234930 |
| Skin odour abnormal | betaine | PT | C0234930 |
| Sleep disorder | betaine | PT | C0851578 |
| Sleep disturbance | betaine | LLT | C0037317 |
| Tooth disorder | betaine | LLT | C0040435 |
| Tooth disorder | betaine | PT | C0040435 |
| Unspecified disorder of skin and subcutaneous tissue | betaine | LLT | C0178298 |
| Upset stomach | betaine | LLT | C0235309 |
| Urethral disorder | betaine | PT | C0041969 |
| Urinary incontinence | betaine | LLT | C0042024 |
| Urinary incontinence | betaine | PT | C0042024 |
| Urinary tract disorder | betaine | LLT | C0042075 |
| Urinary tract disorder | betaine | PT | C0042075 |
| Urticaria | betaine | LLT | C0042109 |
| Urticaria | betaine | PT | C0042109 |
| Vomiting | betaine | LLT | C0042963 |
| Vomiting | betaine | PT | C0042963 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Glycinebetaine used for in pharmaceutical contexts?
Glycinebetaine (CAS 107-43-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Glycinebetaine?
Glycinebetaine has 0 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Hypermethioninaemia, Overdose, Intracranial pressure increased, Brain oedema, Treatment noncompliance. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Glycinebetaine also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Betaine with EU status "permitted".
What clinical phase is Glycinebetaine in?
No phase 1-4 clinical development badge is rendered for Glycinebetaine because the matched compound identifier rows do not contain a max-phase value.